ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 37–48 of 220 project topics
Minimal Residual Disease Monitoring Platform for Personalized Oncology
A precision medicine platform that uses patient-specific mutations identified at diagnosis to monitor for MRD during and after cancer treatment with ultra-sensitive detection (1 mutant copy per 1 million wild-type). This platform generates recurring testing revenue while enabling earlier intervention strategies that reduce patient relapse rates and hospital readmissions.
Molecular Oncology Liquid Biopsy Platforms Click to view more details →
Protein Biomarker Detection via Digital ELISA Microfluidic Chip
A proprietary microfluidic device platform that detects ultra-low abundance cancer-associated proteins (PSA, CEA, HER2) in blood plasma with femtomolar sensitivity, enabling early-stage cancer screening. Revenue comes from per-test fees, instrument placement, reagent sales, and licensing agreements with in vitro diagnostics manufacturers.
Molecular Oncology Liquid Biopsy Platforms Click to view more details →
Integrated Data Management and Clinical Reporting Software for Liquid Biopsy
A HIPAA-compliant SaaS platform that manages liquid biopsy sample workflows, integrates multi-omics data (DNA, RNA, protein), and generates clinical-grade reports with AI-assisted interpretation for oncologists. This software captures recurring subscription revenue while serving as a strategic moat for laboratory operators and reducing manual reporting labor by 60-70%.
Molecular Oncology Liquid Biopsy Platforms Click to view more details →
Next-Generation Sequencing Library Prep Kit Optimized for ctDNA
A commercial consumable kit that prepares circulating tumor DNA for next-generation sequencing with superior coverage uniformity and reduced sequencing artifacts from degraded DNA molecules. This high-margin consumable product generates recurring revenue through adoption by clinical laboratories and research institutions performing liquid biopsy testing at scale.
Molecular Oncology Liquid Biopsy Platforms Click to view more details →
AI-Powered Kinase Selectivity Prediction Platform
A machine learning SaaS platform that predicts off-target kinase binding and selectivity profiles for lead compounds before synthesis. Reduces development timelines by 40% and accelerates candidate selection, enabling faster market entry and reduced R&D costs.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
High-Throughput Kinase Assay Service Bureau
A commercial screening service offering 500+ human kinase profiling assays with real-time data delivery and IC50 determination. Generates recurring revenue through per-assay fees while helping biotech firms eliminate internal screening infrastructure investments.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Resistance Mutation Database and Genomic Analytics Tool
An integrated SaaS platform tracking clinically observed kinase inhibitor resistance mutations with predictive modeling for next-generation drug design. Creates competitive advantage for clients by identifying emerging resistance patterns before market saturation occurs.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Phosphoproteomics Data Integration and Biomarker Discovery Suite
A cloud-based analytics platform aggregating mass spectrometry phosphoproteomics data to identify patient response biomarkers and pathway dependencies. Enables companion diagnostic development and patient stratification services worth millions in licensing agreements.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Structure-Based Kinase Inhibitor Design Workbench
A proprietary computational chemistry tool providing automated scaffold optimization, binding mode prediction, and ADME forecasting for kinase series. Reduces design cycle time by 50% and improves first-pass success rates, justifying premium subscription pricing.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Clinical Trial Patient Monitoring and Efficacy Tracking Dashboard
A real-time digital health platform collecting biomarker and outcome data from kinase inhibitor trials with predictive analytics for responder identification. Accelerates trial enrollment, improves retention, and generates valuable real-world evidence for regulatory submissions.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Kinase-Cancer Model Matching and Patient Sequencing Service
A precision oncology service pairing tumor kinase mutational profiles with matched cell and animal models for functional validation. Monetizes through partnerships with pharmaceutical firms seeking rapid target validation and patient cohort identification.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Multi-Kinase Polypharmacology Assessment and Network Modeling Software
An advanced bioinformatics tool mapping kinase interaction networks and predicting therapeutic synergies for multi-target combination strategies. Licenses to pharma for combination therapy design, opening new revenue streams beyond single-agent development.
Kinase & Signaling Oncology Drug Discovery Click to view more details →